Saturday, February 25, 2006


Hepatitis, Viral


Hepatitis, Viral
Management of viral hepatitis C. J Gastroenterol Hepatol. 2002;17 Suppl: S146-S154. Liaw YF, Leung NW, Chang TT, et al. Effects of extended lamivudine ...

Glucocorticosteroids for viral hepatitis C
No evidence to support or refute glucocorticosteroids for viral hepatitis C Acute infection with viral hepatitis C manifests most commonly no symptoms, ...

Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program in ...
Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program in Acceleration Phase Jan 18, 2006, 18:01, Reviewed by: Dr. Rashmi Yadav ...

Index | CDC Viral Hepatitis
Information and resources on how to identify and protect yourself from hepatitis A through E.

Glucocorticosteroids for viral hepatitis C (Cochrane Review)
Abstract of a systematic review of the effects of health care prepared by the Cochrane Collaboration.

Friday, February 24, 2006


SCH 503034 Jumps on the Fast Track (Hepatitis C Infection)


SCH 503034 Jumps on the Fast Track
Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on this development....

MedMira Rapid Test
The start of the New Year was accompanied by the European Patent Office granting a patent for a rapid HCV test. Now that the technology is here, let's hope the test proves accurate, with high levels of selectivity and specificity....

Cirrhosis Of The Liver
Title: Cirrhosis Of The LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/1/2005

Infectious Mononucleosis
Title: Infectious MononucleosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/14/2005

Doctor: Checklist to Take To Your Doctor's Appointment
Title: Doctor: Checklist to Take To Your Doctor's AppointmentCategory: Health FactsCreated: 7/13/2005Last Editorial Review: 7/14/2005

Ways You Can Get Infected With Hepatitis C(NC)-Hepatitis (Hepatitis C Infection)

Ways You Can Get Infected With Hepatitis C

(NC)-Hepatitis C is spread through contact with infected blood. Here are just some of the ways in which you can be infected with this virus:

Sharing needles, straws, pipes, spoons and other drug-related equipment.

(At least two-thirds of all new hepatitis C infections are drug-use related. Cleaning equipment with bleach does not always effectively kill the virus) p>

Getting a tattoo, body piercing or acupuncture from an operator who does not use sterile equipment or techniques

Being born to a mother with hepatitis C

Getting pierced by a needle or sharp equipment that has infected blood on it ( in a hospital, workplace situation, etc.) p>

People who had blood transfusions before the testing of blood donations became mandatory in 1990 may also be at risk. And, while the risk is low, it is also possible to become infected by sharing personal household articles such as a razor or toothbrush with an infected person. The risk of transmission of hepatitis C during sex is also low, unless both parties have open bleeding sores.

It is estimated that 240, 000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus.

If you think you may be at risk, either now or from past risky activities see a doctor. The virus can be detected with a simple blood test, and there are steps and medications you can take to successfully minimize the effects of the disease if your diagnosis is positive. For more information, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.


Thursday, February 23, 2006


Hepatitis C Infection - Healthy Habits: What Your Doctor Wants You To Know


Healthy Habits: What Your Doctor Wants You To Know
Title: Healthy Habits: What Your Doctor Wants You To KnowCategory: Doctor's ViewsCreated: 12/9/2005Last Editorial Review: 12/22/2005

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Conclusions About Milk Thistle
A May 2005 review of clinical studies which casts doubt on milk thistle's value has recently been re-released into the press. Alternatively, an extensive amount of research supports the continued usage of this herb at higher dosages. Researchers of the...

Immunization: National Immunization Awareness Month
Title: Immunization: National Immunization Awareness MonthCategory: Health FactsCreated: 8/1/2005Last Editorial Review: 8/1/2005

Feedster
No Need to Click Here - I'm just claiming my feed at Feedster....

Wednesday, February 22, 2006


A Good AASLD Meeting Summary (Hepatitis C Infection)


A Good AASLD Meeting Summary
This is a terrific overview article regarding the AASLD meeting. Liz Highleyman did a fantastic job of condensing the key aspects and announcements. One of the most interesting updates/corrections of known information is the upward measurement of the number of...

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Alcoholism Facts
Title: Alcoholism FactsCategory: Health FactsCreated: 8/9/2005Last Editorial Review: 8/29/2005

Tuesday, February 21, 2006


Schering-Plough Drug Gets Fast Track (Hepatitis C Infection)


Schering-Plough Drug Gets Fast Track
AP via Yahoo! Finance - Jan 30 6:44 AM
Drug maker Schering-Plough Corp. said Monday that regulators granted "fast track" status to its experimental hepatitis C treatment.Save to My Web

YOU ARE HERE:
Aidsmap - Jan 23 4:58 PM
Fatigue is more than twice as prevalent as depression during anti-hepatitis C (HCV) treatment in HIV-positive individuals, according to a study presented to the Second International Workshop on HIV and Hepatitis Coinfection, held in Amsterdam earlier this month.Save to My Web

Novartis and Idenix seek European approval of telbivudine (LDT600) for the ...
Financial.de - Feb 07 1:04 AM
Basel, February 7, 2006 - Novartis ( News / Kurs / Chart / Board ) and Idenix Pharmaceuticals, Inc. announced today the European submission of telbivudine (LTD600) for approval as a novel treatment for patients affected by chronic hepatitis B (CHB), a potentially fatal disease estimated to affect more than three million people in Europe1 and over 350 million people worldwide.Save to My Web

YOU ARE HERE:
Aidsmap - Jan 26 4:13 AM
Using liver biopsies the researchers established that 25% of patients with normal alanine aminotransferase (ALT) levels - a key marker of liver function have such severe liver damage that they require anti-hepatitis C treatment, with 13% having cirrhosis, permanent scarring of the liver.Save to My Web

Human Genome Sciences Reports Financial Results for Full Year and Fourth Quarter 2005
[Press Release] PR Newswire via Yahoo! Finance - Feb 09 6:38 AM
Human Genome Sciences, Inc. announced financial results for the quarter and full-year periods ended December 31, 2005, and reiterated guidance for financial results anticipated for 2006.Save to My Web

Monday, February 20, 2006


Hepatitis C Infection - Gastroenterology


Gastroenterology
... Clinicopathological study of viral heaptitis, A. Malik IA, Muzaffar M & Aftab ...

P
... does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B ... treatment of mutant type chronic viral heaptitis B.World J Gastroenterol 2002 ...

Hepatitis C Treatment: 2005-11-27
... Institute of Viral Heaptitis, First Affiliated. Current Opinion in Organ Transplantation ... International Conference on therapies for viral Heaptitis 1999. [ Context Link]. 89 ...

Blogger: Email Post to a Friend
... VLDL levels were significantly decreased in patients of viral heaptitis (22.13 �8 mg/dl) as well ... treatment of mutant type chronic viral heaptitis B. Sien-Sing Yang, Chao ...

Blogger: Email Post to a Friend
... in acute viral hepatitis, viral heaptitis of prolonged duration, acute post ... Viral ehpatitis / Viral hpeatitis / Viral heaptitis / Viral. GeneralPropertiesOfIR01. File Format ...

http://202.154.204.240/content/cmri/edu/E_2_00.xls (MICROSOFT EXCEL)
... Does not Increase the Efficacy of Interferon in the Treatment of Mutant Type Chronic Viral Heaptitis B :-A Pilot Study ...

Sunday, February 19, 2006


Hepatitis C Infection - Ready to Learn: All About Hepatitis C


Ready to Learn: All About Hepatitis C
Ready to Learn: All About Hepatitis C Ready to Learn: All About Hepatitis C This comprehensive online resource for information about Hepatitis C is provided as a public service by Schering Corporation, the medical research and development ...

Hepatitis C Top Articles
HIVandHepatitis.com: The Internet publication with accurate, timely and cutting-edge information on treatment and vaccines for chronic hepatitis B. ... PEG-Intron in adult subjects who have chronic hepatitis C without cirrhosis, and who have failed an adequate ... with What Therapy to Treat Acute Hepatitis C? A cohort study published ...

CNN.com - Pamela Anderson says she has hepatitis C - March 21, 2002
... Actress Pamela Anderson disclosed Wednesday she has hepatitis C and said she contracted the serious liver ... Hepatitis C, a liver disease caused by a viral infection, affects nearly ...

Hepatitis C - MayoClinic.com
Hepatitis C is a highly infectious disease that's usually contracted from contaminated blood.

MedlinePlus Medical Encyclopedia: Hepatitis C
Medical Encyclopedia. Hepatitis C. Contents of this page: Illustrations. Non-A or non-B hepatitis. Hepatitis C is an inflammation of the liver caused by infection with the hepatitis C virus. ... products, or solid organs from a donor who has hepatitis C. Injected street drugs or shared a needle with someone who has hepatitis C. Have been on long ...

The National Institutes of Health (NIH) Consensus Development Program: Management of Hepatitis C: 2002
... Management of Hepatitis C: 2002. National Institutes of Health ... The hepatitis C virus (HCV) is one of the leading known causes of liver disease in the United States ...

A Summary of Chronic Hepatitis C InfectionHepatitis C (Hepatitis C Infection)

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.